Henan Newland Pharmaceutical Co. Ltd. A (301277) — Financial Flexibility Index
Henan Newland Pharmaceutical Co. Ltd. A (301277) has a Financial Flexibility Index of 0.96x as of December 2025. Free cash flow of CN¥218.32 Million (operating CF CN¥116.94 Million minus capex CN¥101.38 Million) represents 1% of total liabilities (CN¥228.49 Million). Also explore net asset momentum of Henan Newland Pharmaceutical Co. Ltd. A to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Henan Newland Pharmaceutical Co. Ltd. A Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Henan Newland Pharmaceutical Co. Ltd. A across 6 annual periods. Check 301277 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)
Year-by-year free cash flow to debt coverage for Henan Newland Pharmaceutical Co. Ltd. A. For the full company profile including market capitalisation, see market value of Henan Newland Pharmaceutical Co. Ltd. A.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | CN¥218.32 Million | CN¥116.94 Million | CN¥228.49 Million | ▲ +8.9% |
| 2024 | 0.88x | CN¥237.55 Million | CN¥126.76 Million | CN¥270.69 Million | ▼ -60.6% |
| 2023 | 2.22x | CN¥355.97 Million | CN¥259.46 Million | CN¥160.02 Million | ▲ +147.1% |
| 2022 | 0.90x | CN¥157.19 Million | CN¥82.85 Million | CN¥174.58 Million | ▲ +216.2% |
| 2021 | 0.28x | CN¥74.48 Million | CN¥49.08 Million | CN¥261.53 Million | ▼ -8.4% |
| 2020 | 0.31x | CN¥64.82 Million | CN¥47.86 Million | CN¥208.57 Million | — |